MY174794A - Anticancer composition - Google Patents

Anticancer composition

Info

Publication number
MY174794A
MY174794A MYPI2012700741A MYPI2012700741A MY174794A MY 174794 A MY174794 A MY 174794A MY PI2012700741 A MYPI2012700741 A MY PI2012700741A MY PI2012700741 A MYPI2012700741 A MY PI2012700741A MY 174794 A MY174794 A MY 174794A
Authority
MY
Malaysia
Prior art keywords
cancer
dentatin
treatment
anticancer composition
breast cancer
Prior art date
Application number
MYPI2012700741A
Inventor
Bustamam Abdul Ahmad
Adan Arbab Ismail
Abdullah Raseedee
Aspollah Sukari Mohammad
Ibrahim Abdel Wahab Siddiq
Yeng Looi Chung
Original Assignee
Univ Putra Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra Malaysia filed Critical Univ Putra Malaysia
Priority to MYPI2012700741A priority Critical patent/MY174794A/en
Publication of MY174794A publication Critical patent/MY174794A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to an anticancer composition use for cure or treatment of cancerous tumors, particularly human breast cancer and human prostate cancer. The pharmaceutical composition comprising an effective amount of dentatin, or dentatin derivative, and a pharmaceutically acceptable carrier for the treatment of cancer. Preferably, the cancer is breast cancer or prostate cancer. ( FIGURE 3 ) The present invention relates to an anticancer composition use for cure or treatment of cancerous tumors, particularly human breast cancer and human prostate cancer. The pharmaceutical composition comprising an effective amount of dentatin, or dentatin derivative, and a pharmaceutically acceptable carrier for the treatment of cancer. Preferably, the cancer is breast cancer or prostate cancer. Most illustrative Figure: Figure 3
MYPI2012700741A 2012-10-06 2012-10-06 Anticancer composition MY174794A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2012700741A MY174794A (en) 2012-10-06 2012-10-06 Anticancer composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2012700741A MY174794A (en) 2012-10-06 2012-10-06 Anticancer composition

Publications (1)

Publication Number Publication Date
MY174794A true MY174794A (en) 2020-05-15

Family

ID=79170447

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012700741A MY174794A (en) 2012-10-06 2012-10-06 Anticancer composition

Country Status (1)

Country Link
MY (1) MY174794A (en)

Similar Documents

Publication Publication Date Title
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
MX2020010496A (en) Inhibitors of lysine specific demethylase-1.
MX2019010601A (en) Combination therapy for treating cancer.
SA515360657B1 (en) Histone demethylase inhibitors
SG10201907684PA (en) Androgen receptor modulator and uses thereof
MX2016007351A (en) Combination therapy for treating cancer.
UA109271C2 (en) Combination of phytocannabinoids and temosolamide for treating glioma
PH12016502354A1 (en) Pharmaceutical composition
MX345788B (en) Combination therapy for the treatment of prostate carcinoma.
CA2908957C (en) Combination therapy comprising a dihydropyrazino-pyrazine compound and an androgen receptor antagonist for treating prostate cancer
MX336761B (en) Compounds for treatment of cancer.
MX2015015434A (en) Targeting corroles for tumor toxicity and mri.
SG191336A1 (en) Compositions and methods of aloe polysaccharides
MX365192B (en) Bendamustine derivatives and related compounds, and medical use thereof cancer therapy.
MY174794A (en) Anticancer composition
UA51405U (en) Method for complex therapy of cancer
GB2519004A (en) Quinone compounds and their uses for the treatment of cancer
MY170968A (en) Compositions and methods of aloe polysaccharides
UA109429C2 (en) IMIDAZOLE DERIVATIVES FOR CANCER TREATMENT